Stereotactic radiofrequency thermocoagulation for giant hypothalamic hamartoma

Area of Science:

• Neurosurgery
• Neurology
• Oncology

Background:

• Giant hypothalamic hamartoma (HH) presents significant challenges in surgical management.
• Stereotactic radiofrequency thermocoagulation (SRT) is an emerging treatment modality for complex brain lesions.

Purpose of the Study:

• To evaluate the feasibility and safety of stereotactic radiofrequency thermocoagulation (SRT) for treating giant hypothalamic hamartomas (HHs).
• To assess the efficacy of SRT in controlling seizures associated with giant HHs.

Main Methods:

• Retrospective review of 16 patients with giant HHs (≥ 30 mm) treated with SRT between 1997 and 2013.
• Analysis of clinical data, including seizure control, complications, and outcomes following SRT procedures.

Main Results:

• SRT was performed on 16 patients with giant HHs, with a median age of 5 years.
• No mortality or permanent morbidity was observed; transient complications occurred in 81.3% of procedures.
• Eighty-one percent of patients achieved freedom from gelastic seizures (GS) after SRT, with repeat procedures being safe.

Conclusions:

• SRT is a minimally invasive and effective surgical option for giant HHs, offering excellent seizure control.
• Repeat SRT is a safe and viable strategy for managing residual seizures.
• SRT represents a feasible single surgical approach for hypothalamic hamartoma, irrespective of tumor size or configuration.